These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 9374921)
41. Gold dermatitis. A clinical and histopathological study. Penneys NS; Ackerman AB; Gottlieb NL Arch Dermatol; 1974 Mar; 109(3):372-6. PubMed ID: 4273615 [No Abstract] [Full Text] [Related]
42. Interferon-gamma secreted from peripheral blood mononuclear cells as a possible diagnostic marker for allergic contact dermatitis to gold. Christiansen J; Färm G; Eid-Forest R; Anderson C; Cederbrant K; Hultman P Contact Dermatitis; 2006 Aug; 55(2):101-12. PubMed ID: 16930235 [TBL] [Abstract][Full Text] [Related]
43. [Cutaneous side effects of gold therapy. Clinical and histologic results]. Hofmann C; Burg G; Jung C Z Rheumatol; 1986; 45(3):100-6. PubMed ID: 2944308 [TBL] [Abstract][Full Text] [Related]
44. [[Gold antirheumatic drug: desired and adverse effects of Au(I) and Au(III) [corrected] on the immune system]. Griem P; Gleichmann E Z Rheumatol; 1996; 55(5):348-58. PubMed ID: 9036720 [TBL] [Abstract][Full Text] [Related]
45. Maintenance chrysotherapy in rheumatoid arthritis: a comparison of 2 dose schedules. Griffin AJ; Gibson T; Huston G; Taylor A Ann Rheum Dis; 1981 Jun; 40(3):250-3. PubMed ID: 6787995 [TBL] [Abstract][Full Text] [Related]
46. Risk factors that may influence development of side effects of gold sodium thiomalate. Kay EA; Jayson MI Scand J Rheumatol; 1987; 16(4):241-5. PubMed ID: 2957787 [TBL] [Abstract][Full Text] [Related]
47. Chrysotherapy provoking exacerbation of contact hypersensitivity to nickel. Wijnands MJ; Perret CM; van den Hoogen FH; van de Putte LB; van Riel PL Lancet; 1990 Apr; 335(8693):867-8. PubMed ID: 1969601 [No Abstract] [Full Text] [Related]
48. IV N-acetylcysteine treatment of hematologic reactions to chrysotherapy. Godfrey NF; Peter A; Simon TM; Lorber A J Rheumatol; 1982; 9(4):519-26. PubMed ID: 6813467 [TBL] [Abstract][Full Text] [Related]
49. Contact allergy to gold after systemic administration of gold for rheumatoid arthritis. Wicks IP; Wong D; McCullagh RB; Fleming A Ann Rheum Dis; 1988 May; 47(5):421-2. PubMed ID: 3133993 [TBL] [Abstract][Full Text] [Related]
50. Liver dysfunction associated with gold therapy for rheumatoid arthritis. Edelman J; Donnelly R; Graham DN; Percy JS J Rheumatol; 1983 Jun; 10(3):510-1. PubMed ID: 6411922 [TBL] [Abstract][Full Text] [Related]
51. Gold in the dermis following chrysotherapy: histopathology and microanalysis. Keen CE; Brady K; Kirkham N; Levison DA Histopathology; 1993 Oct; 23(4):355-60. PubMed ID: 7905458 [TBL] [Abstract][Full Text] [Related]
52. Nitritoid reactions: case reports, review, and recommendations for management. Arthur AB; Klinkhoff A; Teufel A J Rheumatol; 2001 Oct; 28(10):2209-12. PubMed ID: 11669157 [TBL] [Abstract][Full Text] [Related]
53. Parenteral gold preparations. Efficacy and safety of therapy after switching from aurothioglucose to aurothiomalate. van Roon EN; van de Laar MA; Janssen M; Kruijsen MW; Jansen TL; Brouwers JR J Rheumatol; 2005 Jun; 32(6):1026-30. PubMed ID: 15940762 [TBL] [Abstract][Full Text] [Related]
54. [Chrysotherapy and side effects (author's transl)]. Eberl R Wien Klin Wochenschr Suppl; 1974; 25():3-22. PubMed ID: 4279096 [No Abstract] [Full Text] [Related]
55. Obstructive sialadenitis caused by intraparotid deposits of gold salts: a case report. Zuazua JS; de la Fuente AM; Rodriguez JC; Garcia GB; Rodriguez AP Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 1996 Jun; 81(6):649-51. PubMed ID: 8784895 [TBL] [Abstract][Full Text] [Related]
56. [A preliminary observation of chrysotherapy for rheumatoid arthritis]. Zhang NZ Zhonghua Nei Ke Za Zhi; 1983 Mar; 22(3):149-51. PubMed ID: 6409538 [No Abstract] [Full Text] [Related]